Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase

Author:

Zimran Ari1,Pastores Gregory M.2,Tylki-Szymanska Anna3,Hughes Derralynn A.4,Elstein Deborah1,Mardach Rebecca5,Eng Christine6,Smith Laurie7,Heisel-Kurth Margaret8,Charrow Joel9,Harmatz Paul10,Fernhoff Paul11,Rhead William12,Longo Nicola13,Giraldo Pilar14,Ruiz Juan A.15,Zahrieh David15,Crombez Eric15,Grabowski Gregory A.16

Affiliation:

1. Shaare Zedek Medical Center and Hebrew University-Hadassah Medical School; Jerusalem; Israel

2. New York University School of Medicine; New York; New York

3. Children's Memorial Health Institute; Warsaw; Poland

4. Royal Free Hospital, University College London School of Medicine; London; United Kingdom

5. Kaiser Permanente; Los Angeles; California

6. Baylor College of Medicine; Houston; Texas

7. Children's Mercy Hospital; Kansas City; Missouri

8. Children's Hospitals of Minnesota; Minneapolis; Minnesota

9. Ann and Robert H. Lurie Children's Hospital of Chicago; Chicago; Illinois

10. Children's Hospital Oakland; Oakland; California

11. Emory University; Decatur; Georgia

12. Children's Hospital of Wisconsin; Milwaukee; Wisconsin

13. University of Utah; Salt Lake City; Utah

14. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) and Hospital Universitario Miguel Servet; Zaragoza; Spain

15. Shire Human Genetic Therapies; Lexington; Massachusetts

16. Cincinnati Children's Hospital Medical Center; Cincinnati; Ohio

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3